AKT1 and cancer: However, although some reports have shown that signaling pathways, such as PI3K/AKT, are involved in the regulation of PD-L1 mediated EMT [7], the detailed molecular mechanism of how abnormal expression of PD-L1 regulates the EMT in cancer cells still remains largely unexplored.